Emerging roles of microRNAs and other non-coding transcriptome in muscular dystrophies. [PDF]
Abdelrehim FG +5 more
europepmc +1 more source
Engineered mischarged transfer RNAs for correcting pathogenic missense mutations. [PDF]
Hou Y +10 more
europepmc +1 more source
Uncovering compound heterozygous <i>DYSF</i> variants in a Chinese family affected by limb-girdle muscular dystrophy type 2B. [PDF]
Li J +7 more
europepmc +1 more source
LGMD. Identification, description and classification. [PDF]
Angelini C.
europepmc +1 more source
Treatabolome for finely targeting muscle pathology in LGMD. [PDF]
Angelini C.
europepmc +1 more source
Limb-girdle muscular dystrophy type 2A (LGMD2A) is a recessive genetic disorder caused by mutations in the cysteine protease calpain 3 (CAPN3) that leads to selective muscle wasting.
Bourg N +12 more
core
Cell therapy for Duchenne muscular dystrophy: promises, challenges, and controversies. [PDF]
Łoboda A, Dulak J.
europepmc +1 more source
Clinical, pathological, imaging, and genetic characterization in a Taiwanese cohort with limb-girdle muscular dystrophy. [PDF]
Liang WC +9 more
europepmc +1 more source
Co-occurrence of CAPN3 homozygous mutation and CCTG expansion in the CNBP gene in a patient with muscular dystrophy. [PDF]
Radziwonik-Frączyk W +6 more
europepmc +1 more source
A survey on mutation spectrum in Iranian patients with limb-girdle muscular dystrophies. [PDF]
Khalilian S +6 more
europepmc +1 more source

